897 related articles for article (PubMed ID: 27591499)
41. Transgenic mice overexpressing neuregulin-1 model neurofibroma-malignant peripheral nerve sheath tumor progression and implicate specific chromosomal copy number variations in tumorigenesis.
Kazmi SJ; Byer SJ; Eckert JM; Turk AN; Huijbregts RP; Brossier NM; Grizzle WE; Mikhail FM; Roth KA; Carroll SL
Am J Pathol; 2013 Mar; 182(3):646-67. PubMed ID: 23321323
[TBL] [Abstract][Full Text] [Related]
42. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
43. Malignant peripheral nerve sheath tumors.
Gupta G; Maniker A
Neurosurg Focus; 2007 Jun; 22(6):E12. PubMed ID: 17613203
[TBL] [Abstract][Full Text] [Related]
44. Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.
Kresbach C; Dottermusch M; Eckhardt A; Ristow I; Paplomatas P; Altendorf L; Wefers AK; Bockmayr M; Belakhoua S; Tran I; Pohl L; Neyazi S; Bode H; Farschtschi S; Well L; Friedrich RE; Reuss D; Snuderl M; Hagel C; Mautner VF; Schüller U
Neuro Oncol; 2023 Sep; 25(9):1644-1655. PubMed ID: 36866403
[TBL] [Abstract][Full Text] [Related]
45. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment.
Attia S; Guirguis M; Le LQ; Chhabra A
Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998
[TBL] [Abstract][Full Text] [Related]
46. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems.
Rodriguez FJ; Folpe AL; Giannini C; Perry A
Acta Neuropathol; 2012 Mar; 123(3):295-319. PubMed ID: 22327363
[TBL] [Abstract][Full Text] [Related]
47. Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of
Cook GJR; Lovat E; Siddique M; Goh V; Ferner R; Warbey VS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1845-1852. PubMed ID: 28589254
[TBL] [Abstract][Full Text] [Related]
48. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1.
Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE
Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778
[TBL] [Abstract][Full Text] [Related]
49. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595
[TBL] [Abstract][Full Text] [Related]
50. Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.
Graham DS; Russell TA; Eckardt MA; Motamedi K; Seeger LL; Singh AS; Bernthal NM; Kalbasi A; Dry SM; Nelson SD; Elashoff D; Levine BD; Eilber FC
Am J Clin Oncol; 2019 Oct; 42(10):739-743. PubMed ID: 31436746
[TBL] [Abstract][Full Text] [Related]
51. Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.
Uthoff J; De Stefano FA; Panzer K; Darbro BW; Sato TS; Khanna R; Quelle DE; Meyerholz DK; Weimer J; Sieren JC
J Neuroradiol; 2019 May; 46(3):179-185. PubMed ID: 29958847
[TBL] [Abstract][Full Text] [Related]
52. Malignant Peripheral Nerve Sheath Tumors of the Brachial Plexus: A Single-Center Experience on Diagnosis, Management, and Outcomes.
Donaldson EK; Winter JM; Chandler RM; Clark TA; Giuffre JL
Ann Plast Surg; 2023 Apr; 90(4):339-342. PubMed ID: 36752552
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical study of GLUT-1 in oral peripheral nerve sheath tumors.
Salla JT; Johann AC; Lana AM; do Carmo MA; Nunes FD; Mesquita RA
Oral Dis; 2008 Sep; 14(6):510-3. PubMed ID: 18826382
[TBL] [Abstract][Full Text] [Related]
54. Malignant peripheral nerve sheath tumor: pathology and genetics.
Thway K; Fisher C
Ann Diagn Pathol; 2014 Apr; 18(2):109-16. PubMed ID: 24418643
[TBL] [Abstract][Full Text] [Related]
55. Other Nerve Sheath Tumors of Brain and Spinal Cord.
Petrov M; Sakelarova T; Gerganov V
Adv Exp Med Biol; 2023; 1405():363-376. PubMed ID: 37452945
[TBL] [Abstract][Full Text] [Related]
56. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract][Full Text] [Related]
57. Clinical analysis of spinal stereotactic radiosurgery in the treatment of neurogenic tumors.
Shin DW; Sohn MJ; Kim HS; Lee DJ; Jeon SR; Hwang YJ; Jho EH
J Neurosurg Spine; 2015 Oct; 23(4):429-37. PubMed ID: 26140405
[TBL] [Abstract][Full Text] [Related]
58. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study.
Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S
Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous Malignant Peripheral Nerve Sheath Tumor.
Luzar B; Falconieri G
Surg Pathol Clin; 2017 Jun; 10(2):337-343. PubMed ID: 28477884
[TBL] [Abstract][Full Text] [Related]
60. The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1.
Gesundheit B; Parkin P; Greenberg M; Baruchel S; Senger C; Kapelushnik J; Smith C; Klement GL
J Pediatr Hematol Oncol; 2010 Oct; 32(7):548-53. PubMed ID: 20686424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
